Ventum Financial Lowers WELL Health Technologies (TSE:WELL) Price Target to C$7.00

WELL Health Technologies (TSE:WELLGet Free Report) had its price target dropped by equities research analysts at Ventum Financial from C$8.00 to C$7.00 in a report released on Tuesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Ventum Financial’s price objective points to a potential upside of 58.37% from the company’s previous close.

Separately, CIBC lifted their price target on WELL Health Technologies from C$4.75 to C$5.00 in a research report on Friday, August 16th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of C$6.97.

Check Out Our Latest Stock Analysis on WELL Health Technologies

WELL Health Technologies Price Performance

WELL opened at C$4.42 on Tuesday. The stock has a 50-day moving average price of C$4.44 and a 200-day moving average price of C$4.28. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. The firm has a market cap of C$1.10 billion, a PE ratio of 7.75, a P/E/G ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 1 year low of C$3.41 and a 1 year high of C$5.05.

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.

Recommended Stories

Analyst Recommendations for WELL Health Technologies (TSE:WELL)

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.